Rockefeller Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-950
| Closed | -$361K | – | 4226 |
|
|
2022
Q4 | $361K | Sell |
950
-93,300
| -99% | -$31.1M | ﹤0.01% | 1400 |
|
|
2022
Q3 | $23.2M | Sell |
94,250
-1,068
| -1% | -$288K | 0.12% | 187 |
|
|
2022
Q2 | $23.6M | Sell |
95,318
-1,104
| -1% | -$298K | 0.13% | 175 |
|
|
2022
Q1 | $31.9M | Buy |
96,422
+653
| +0.7% | +$201K | 0.15% | 153 |
|
|
2021
Q4 | $34.4M | Buy |
95,769
+153
| +0.2% | +$51.7K | 0.16% | 144 |
|
|
2021
Q3 | $31.1M | Sell |
95,616
-16
| -0% | -$5.42K | 0.16% | 147 |
|
|
2021
Q2 | $29.8M | Sell |
95,632
-3,068
| -3% | -$941K | 0.17% | 144 |
|
|
2021
Q1 | $31.5M | Sell |
98,700
-1,097
| -1% | -$351K | 0.21% | 116 |
|
|
2020
Q4 | $32.4M | Sell |
99,797
-2,939
| -3% | -$813K | 0.25% | 103 |
|
|
2020
Q3 | $28.5M | Sell |
102,736
-1,056
| -1% | -$304K | 0.27% | 94 |
|
|
2020
Q2 | $25.1M | Buy |
103,792
+96
| +0.1% | +$19.3K | 0.26% | 86 |
|
|
2020
Q1 | $15.1M | Buy |
103,696
+691
| +0.7% | +$115K | 0.2% | 113 |
|
|
2019
Q4 | $17.6M | Buy |
103,005
+1,730
| +2% | +$321K | 0.22% | 101 |
|
|
2019
Q3 | $18M | Buy |
101,275
+4,988
| +5% | +$1.08M | 0.24% | 91 |
|
|
2019
Q2 | $25.1M | Sell |
96,287
-1,269
| -1% | -$337K | 0.35% | 66 |
|
|
2019
Q1 | $27.9M | Sell |
97,556
-4,020
| -4% | -$1.34M | 0.4% | 59 |
|
|
2018
Q4 | $33M | Sell |
101,576
-2,105
| -2% | -$731K | 0.58% | 44 |
|
|
2018
Q3 | $46.6M | Sell |
103,681
-4,073
| -4% | -$1.61M | 0.71% | 40 |
|
|
2018
Q2 | $44.1M | Sell |
107,754
-30,762
| -22% | -$11.1M | 0.72% | 40 |
|
|
2018
Q1 | $40.3M | Buy |
+138,516
| New | +$35.1M | 0.67% | 43 |
|